Training and Education

Assay Kits, Biomarkers and Antibodies for Investigating Oxidative Stress

AMSBIO has expanded its range of antibodies, biomarkers and assay kits related to free radicals (ROS and RNS), non-radical reactive derivatives (or oxidants) and antioxidants for researchers investigating the mechanism of oxidative stress. It is widely recognized free radicals play...

Services to Accelerate Genome Editing Research

AMSBIO has expanded its range of custom gene editing services to complement its extensive portfolio of off-the-shelf CRISPR/Cas9 products. A powerful technology, widely used in genome science, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) / Cas9 is a simple and...

Custom Biofluid & Tissue Procurement Service

Global provider of human and animal biospecimens - AMSBIO offers a custom procurement service enabling researchers to source specific biofluid and tissue samples which are not already available in their extensive biorepository. To support increasingly complex research, AMSBIO aims to...

Tools to advance cellular metabolism research

AMSBIO has expanded its range of top quality, high-performance assay kits, antibodies, enzymes, and substrates for cellular metabolism research. Cell metabolism is the series of chemical synthesis (Anabolism) and degradation (Catabolism) reactions of complex macromolecules, catalyzed by enzymes that take...

C2C Announces New MD and Commercial Director

Connect 2 Cleanrooms Ltd (C2C) has appointed Nicola Coull as its new Managing Director and Oliver Barker as Commercial Director. C2C provides integrated cleanroom services and was acquired by USA-based Angstrom Technology in January 2022 to be part of the...

Expanded range of nucleic acid extraction kits for pathogens detection

AMSBIO has added several new products to its range of magnetic bead based nucleic acid extraction kits for pathogens detection. The MagSi-NA Pathogens MSP (Multiple Sample Pooling) kit sets a benchmark for automated isolation of nucleic acids (RNA and DNA)...

Microplate Slit Seals maintain integrity of reconstituted samples for several days

RAPID Slit Seal microplate seals from BioChromato are designed to maintain the integrity of reconstituted samples over several days thereby enabling high precision repeat analysis. Used in pharmaceutical, biotech and healthcare labs worldwide, RAPID Slit Seal is a unique self-closing...

US Research reveals the role of Heparan Sulfate in Obesity

AMSBIO reports how researchers at the Washington University School of Medicine (St. Louis, USA) have used their 10E4 Heparan Sulfate (HS) antibody in pioneering obesity research to quantify the role of HS in the process of intercellular mitochondria transfer...

One-step ELISA Experiments

AMSBIO announces the launch of the QuicKey Pro™ range of ELISA kits – new easy-to-use assays that require just one step of washing, and one step of sample addition, resulting in a whole experiment taking only 90 minutes. Compared with...

Isolation of High Purity Exosomes

AMSBIO is a leading supplier of high purity exosomes using isolation methods including traditional differential and gradient ultracentrifugation, immunoaffinity, size exclusion chromatography as well as precipitation / low speed centrifugation. Exosomes are small endosome derived lipid nanoparticles actively secreted by...

Polyspecific antibodies for cancer research

AMSBIO announce a new range of high-quality bispecific antibodies (BsAbs) and trispecific antibodies (TsAbs) that can used to provide enhanced cancer therapeutic efficacy and/or safety compared to what can be achieved with conventional monospecific antibodies. The concept of using a...

Aptamers for cancer diagnosis and therapy

AMSBIO offer an extensive range of aptamers targeting many human proteins linked to cancer. Aptamers bind to target molecules with the same affinity and specificity as antibodies but offer significant advantages, in particular a lack of immunogenicity, which makes...

Cellular protein factories may contribute to ageing and related diseases

Research finds that the cellular assembly line that produces proteins can stall with age, triggering a snowball effect that increases the output of misfolded proteins. In humans, clumps of misfolded proteins contribute to age-linked Alzheimer’s and Parkinson’s diseases. Taylor...

T cells: their increasing significance in infectious disease diagnosis and research

Peter Wrighton-Smith, CEO of Oxford Immunotec, talks to Bioscience Today about growing understanding of the importance of T cells in protecting us from disease, as well as their critical role in measuring immune responses to infection. The coronavirus (COVID-19) pandemic,...

Potential breakthrough in treatment of rare disease

Biotech company Actigen has initiated a clinical development programme for GNR-055, a potentially breakthrough treatment for the life-limiting, rare disease mucopolysaccharidosis II (MPS II) (also known as Hunter syndrome). Occurring in around 1 in 100,0000–170,000 births, MPS II presents...

New treatment on horizon against ‘parasite’ mitochondria

A groundbreaking study has solved the old enigma in mitochondrial DNA disorders and advances the prospect of enhanced treatments for patients. It not only resolves a long-standing conundrum in the molecular pathology of mitochondrial disease, but offers an exciting opportunity...

Breakthrough access to epigenome and streamlines workflows

In an industry first, biotech pioneers PacBio announce significant enhancements to the Sequel II/IIe platform include methylation calling in native DNA, greatly accelerated sample preparation, and support for gene therapy applications. Californian-based Pacific Biosciences (PacBio) has revealed the release of...

Why is Diligent Due Diligence Important?

Alex Bone, Patent Attorney, Partner,  AA Thornton. Background Biopharma merger and acquisition activity was lower in 2021 than in recent years, but the top 10 deals still reached a combined value of over $50 billion. The main value of such deals rarely...

Durham University launches new degree in Plant Biotechnology and Enterprise

Durham University has launched a new MSc in Plant Biotechnology and Enterprise designed to provide the fundamental knowledge and skills to produce future scientists specialising in plant biotechnology. Students’ will gain the technical and scientific skills needed to support increased...

Cancer cell ‘switch-off’ could aid deadly brain tumour treatment

Researchers believe they may have found a way to strengthen possible treatments for glioblastoma and reduce the speed at which the aggressive tumour progresses. Glioblastoma is the most common primary brain tumour in adults, and, as often resistant to treatment,...

Could ‘bee glue’ combat drug-resistant bacteria

A remarkable material known as propolis - found in beehives - is the subject of a new two-year study by the University of Bradford and Whitby-based natural remedy company Nature’s Laboratory. Propolis is a biscuity brown, crumbly substance used in...

A Tale of Two Crises

Unfortunately, it appears that being slow to recognise a crisis is part of the human condition, and medical research has had its fair share. Often there needs to be a key event (or series of events) to highlight the...

Electronics inspired by the qualities of human skin

Human interactions with robots could soon be revolutionised with ‘skin-inspired’ electronics. Chemical engineers at Stanford have already discovered a groundbreaking way to create an elastic light-emitting polymer. Now they have developed stretchy colour displays which could transform the way users interact...

Evonetix demonstrates novel enzymatic DNA synthesis method

Proprietary thermally-controlled synthesis chemistry will enable production of high quality DNA at scale, making it a key milestone in the development of Evonetix’s benchtop DNA synthesis platform. EVONETIX LTD (‘Evonetix’), the synthetic biology company specialising in semiconductor technology for DNA...

Closing the Loop on personalised healthcare

Precision medicine using personalised treatments has entered mainstream healthcare. Closed Loop Medicine Ltd aims to level the playing field further with its drug and digital combination products. The Cambridge-based healthcare company is developing drug and digital therapeutic combination products centred...

The time is now: how bioscience can build its talent pipeline

Benn Chacksfield, Head of Propositions at Tiro, says employers should consider alternative avenues of recruitment to avert the looming skills crisis. The bioscience sector has never been more prominent in public consciousness in the wake of the nation’s COVID-19 testing...

The future of healthcare: enabling a culture of prevention though tech

Our existing healthcare systems are in need of an overdue shift in focus, says Simon Pavitt, Chief Operating Officer, London Technology Club. While the compassion, energy and dedication of healthcare workers should never be undervalued, the reality is that...

What happens in our brain when we die

Neuroscientists have recorded the activity of a dying human brain and discovered rhythmic brain wave patterns similar to those during dreaming, memory recall, and meditation. A new study suggests an explanation for vivid life recall in near-death experiences. Maryam...

Cytiva supports global biopharma industry with new site in Cardiff, Wales

Cardiff site will manufacture single-use bioprocessing technologies used to make vaccines and biopharmaceuticals for global customers. Part of a £300 million investment over two years with Pall Life Sciences into UK operations. Cytiva, a global life sciences leader, is...

DMT-assisted therapy: changing the way we think about depressive disorders

A ‘spirit molecule’ from the Amazon could be a game changer in the treatment of major depressive disorders. Dr Carol Routledge, of Small Pharma, talks to Karen Southern about her pioneering work with DMT. Psychedelic assisted drug therapy is not...